It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...
7 Hence, within the first year of treatment of osteoporosis in patients with celiac disease, the use of an antiresorptive agent to reduce bone loss is not recommended. In the described case ...
the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...
Treatment-dependent relative risks (or therapy ... identified in the Lips [25] review of studies of quality of life in osteoporosis. The model used a 57% relative risk reduction (RR = 0.43 ...